Overexpression of Fas and FasL Is Associated with Infectious Complications and Severity of Experimental Severe Acute Pancreatitis by Promoting Apoptosis of Lymphocytes by unknown
Overexpression of Fas and FasL Is Associated with Infectious
Complications and Severity of Experimental Severe Acute
Pancreatitis by Promoting Apoptosis of Lymphocytes
Liao Pinhu,1,4 Yueqiu Qin,1 Bin Xiong,2 Yanwu You,1 Jun Li,1 and Suren R. Sooranna3
Abstract—This study investigated the relationship of Fas and Fas ligand (FasL) expression and apopto-
sis of lymphocytes in relation to the pathogenic immune response and infectious complications observed
in experimental severe acute pancreatitis in mice. Forty male Balb/c mice were randomly divided into
control, mild (MAP), and severe acute pancreatitis (SAP) groups. Overexpression of Fas/FasL
messenger ribonucleic acid (mRNA) and protein was observed in spleen-derived lymphocytes
in SAP (p<0.01). Apoptosis of these resulted in a depletion of circulating lymphocytes in this
group (p<0.05). A further significant change in the SAP group with infectious complications
was observed. A positive relationship was found between the Fas/FasL expression and lym-
phocyte apoptosis, and negative relationships were observed between Fas/FasL expression and
CD4+ and CD19+ lymphocytes and the CD4+/CD8+ ratio in SAP mice (p<0.01). The results
suggest that the overexpression of Fas/FasL is associated with infectious complications and
severity of experimental severe acute pancreatitis by promoting apoptosis of lymphocytes.
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INTRODUCTION
Severe acute pancreatitis (SAP) is a disease that de-
velops from local pancreatic inflammation to overwhelm-
ing systemic inflammation. It is associated with severe
infectious complications and multiple organ failure. Ne-
crotic pancreatic tissue in SAP is one of the main reasons
that lead to systemic inflammation and mortality [1, 2]. It
has been widely accepted that uncontrolled inflammatory
response plays a key role in the occurrence of infection and
sepsis [3, 4] and that the immune response such as
immunosuppression is also involved [5, 6]. With the
development of systemic inflammation, pro- and anti-in-
flammatory cytokines are released into the circulation,
causing compensatory anti-inflammatory response syn-
drome (CARS) and subsequent immune deficiency or im-
munosuppression [7–9] which renders the host susceptible
to secondary infections and to systemic sepsis [10]. How-
ever, the molecular mechanisms involved in the pathogen-
esis of this disease remain poorly understood. Extensive
apoptosis of lymphocytes and intestinal epithelial cells in
patients with sepsis, shock, and multiple organ dysfunction
has been found, and these results suggested that the chang-
es of immune status contribute to the immunosuppression
[11]. Prevention of lymphocyte apoptosis has been shown
to improve immunological impairment and survival in
septic mice [12, 13].
The Fas molecule (also known as CD95 or Apo-1) is
a type I transmembrane protein, and Fas ligand (FasL) is
the natural ligand of Fas and is a type II transmembrane
protein. Fas is widely expressed, while FasL expression is
observed mainly in activated lymphocytes and vascular
endothelial cells [14]. A previous work has demonstrated
that Fas and FasL play critical roles in delivering death
signals to the immune system, and interactions of Fas–
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FasL can initiate the death signal pathway leading to lym-
phocyte apoptosis [15–17]. Mutation or downregulation of
the expression of Fas and FasL genes resulted in lympho-
cyte proliferation and autoimmune disease [18, 19]. In
contrast, upregulation of the expression of Fas and FasL
may cause excessive apoptosis of lymphocytes leading to
immunological impairment and immunosuppression [20].
Recent studies have shown that Fas/FasL-mediated apo-
ptosis of pancreatic acinar cells, intestinal epithelial cells,
and Kupffer cells occur in acute pancreatitis [21–23]. De-
creased numbers of peripheral blood and spleen lympho-
cytes had been found in SAP rats [24]. The numbers of
CD4+, CD8+, and CD20+ T lymphocytes in SAP patients
were significantly lower than the normal ranges. The
numbers of CD4+ and CD8+ T lymphocytes decreased
more significantly in patients with infection [5]. Although
Fas and FasL have been shown as the main factors that lead
to apoptosis of lymphocytes, the expression levels of Fas/
FasL and apoptosis in spleen lymphocytes of SAP need to
be studied further. The relationships between Fas/FasL
expression, apoptosis of spleen lymphocytes, changes of
immune status, and infectious complications in
experimental SAP remain largely unknown.
The aim of this study was to investigate the role of
Fas/FasL expression and the apoptosis of lymphocytes, the
changes of immune status, and the infectious complica-
tions in an experimental severe acute pancreatitis mice
model.
MATERIALS AND METHODS
Animals. The study was approved by the Committee
on Animal Care and Use of Youjiang Medical University
for Nationalities and was performed according to the Na-
tional Institute of Health guidelines. Forty male Balb/c
mice (8–12 weeks old) weighing 25 to 30 g were used
and were maintained at 2,225 °C and 40–60 % relative
humidity using a 12-h light/dark cycle. They were fasted
for 12 h prior to experiments but were allowed free access
to tap water.
Experimental Protocol. The animals were randomly di-
vided into a control group (injected with normal saline, n=
10) and two groups whereby pancreatitis was induced with
caerulein. The mild acute pancreatitis (MAP) group (n=
10) was induced by six hourly intravenous injections of
caerulein (5 μg/kg; C9026 Sigma-Aldrich, USA) [25, 26].
The SAP group (n=20) was divided into two subgroups
according to the result of bacterial culture: a subgroup with
infection complications (n=12) and a subgroup without
infectious complication (n=8). The mice in the SAP group
received six hourly intraperitoneal injections of caerulein
(50 μg/kg) and then a single intraperitoneal injection of
10 mg/kg lipopolysaccharide (LPS; Escherichia coli
055:B5, L2880, Sigma-Aldrich, USA) after the last
caerulein injection as previously described [27–30]. Ani-
mals were anesthetized with 50 mg/kg pentobarbital 12 h
after the last injection. Blood samples were collected by
cardiac puncture for measuring serum amylase activity and
lipase activity and to detect circulating lymphocyte subsets.
The spleen was harvested; a part of which was fixed and
embedded in paraffin wax for immunohistochemical and
TdT-mediated dUTP nick-end labeling (TUNEL) staining,
and the other part was immediately processed for splenic
lymphocyte suspensions as described below. The pancreas
was also carefully removed for histological evaluations and
bacterial culture. The mesenteric lymph node (MLN) com-
plex was harvested for bacterial culture. All of these pro-
cedures were performed under aseptic conditions.
Biochemical Assays. Blood samples (400 μL) were
collected by cardiac puncture and transferred into 0.5-mL
centrifugation tubes, allowed to clot, and then centrifuged
at 3,000×g for 5 min. The serum was collected and stored.
Serum amylase and lipase activities were determined using
commercially available kits (Sigma-Aldrich, USA).
Histological Examination. The pancreas was fixed in
10 % neutral formaldehyde, embedded in paraffin wax,
and then was sectioned (4 μm thickness) and stained with
hematoxylin and eosin (HE). The sections were examined
and scored by two pathologists who were blinded to the
experimental protocol. A scoring system previously de-
scribed by Schmidt et al. [31] was used to score the tissues
for pancreatic edema, acinar necrosis, inflammation, and
hemorrhage.
Bacterial Examination. TheMLN complex and the oth-
er parts of the pancreas were weighed and transferred into
sterile tubes containing 0.5 mL of precooled phosphate-
buffered saline (PBS) and were then homogenized with a
glass grinder. The homogenates were placed into brain–
heart culture medium and plated onto sheep blood agar,
MacConkey agar, and Columbia calistin nalidixic acid
(CNA) agar (Becton Dickinson and Company, USA). Af-
ter 48 h of incubation at 37 °C, colonies were identified and
results were expressed as colony-forming units (CFUs) per
gram of tissue.
Preparat ion of Lymphocytes Derived from the
Spleen. Single cell suspensions of spleen were made
by grinding the spleen on nylon nets (200 mesh) in
35-mm petri dishes containing 5 mL of mouse lym-
phocyte isolation liquid (Dakewe, Shenzhen, China).
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The cell suspensions of spleen were transferred into
centrifuge tubes and covered with 300 μL of RPMI
1640 culture medium. Lymphocytes were harvested
using density gradient centrifugation (at 800×g for
20 min). After counting and observing cell morphol-
ogy under a microscope, RNA and protein of these
lymphocytes were immediately extracted as follows.
Real-Time Polymerase Chain Reaction (PCR). Total RNA
of splenic lymphocytes was extracted with chloroform and
TRIzol (Invitrogen, USA) according to the TRIzol kit pro-
tocol. RNA (2 μg) was reverse transcribed (RT) into com-
plementary deoxyribonucleic acid (cDNA) using M-MLV
reverse transcriptase with Oligo dT (Invitrogen, USA).
cDNAwas aliquoted and stored at −80 °C until used.Mouse
Fas, FasL, and actin, beta (ACTB) primers were designed
using Primer Express software (version 3.0). Polyacryl-
amide gel electrophoresis (PAGE) level purification primers
of mouse Fas (NM_007987.2), FasL (NM_010177.4), and
ACTB (NM_007393.3) were synthesized (Invitrogen Com-
pany, Shanghai, China). Fas primer sequence is forward 5′-
ATGCACACTCTGCGATGAAG-3′ and reverse 5′-
CAGTGTTCACAGCCAGGAGA-3′; FasL primer se-
quence is forward 5′-GCAGAAGGAACTGGCAGAAC-
3′ and reverse 5′-TTAAATGGGCCACACTCCTC-3′; and
ACTB primer sequence is forward 5′-GGGAATGG
GTCAGAAGGACT-3 ′ and reverse 5 ′-CTTCTC
CATGTCGTCCCAGT-3′. The expression levels of Fas
and FasL were semiquantitatively measured by real-time
PCR (Bio-Rad iQ5, USA) using QuantiFast SYBR green
PCR kit (cat. 204054, Qiagen, Germany). After 5 min of
initial activation at 95 °C, PCRwas carried out for 40 cycles
at 95 °C for 10 s and 61.3 °C for 30 s. ACTBwas performed
simultaneously and used as the housekeeping gene. The
threshold cycle (Ct) value was measured, and the compara-
tive gene expression was calculated by 2−ΔΔCt method as
described previously [32]. Two percent agarose gel
electrophoresis was used to identify amplification products.
Western Blot Analysis. Splenic lymphocytes were dilut-
ed in lysis buffer (50 mMTris–HCl, pH 7.4, 150 mMNaCl,
1 % Triton X-100, 0.1 % sodium dodecyl sulfate (SDS),
2 mM ethylenediaminetetraacetic acid (EDTA), 0.1 mM
EGTA, 5 mM NaF, 1 mM Na3VO4, 5 mM Na2PO4, and
1× proteinase inhibitor cocktail (Beyotime Institute of Bio-
technology, China)) on ice for 30 min and then centrifuged
(12,000 rpm, 20 min) at 4 °C. The supernatants were col-
lected, aliquoted, and stored at −80 °C until used. Western
blot analysis of Fas and FasL was conducted and quantified
as described [33, 34]. After separating on SDS-PAGE gel
electrophoresis, proteins were transferred to polyvinylidene
difluoride (PVDF) membranes (MerckMillipore, USA) and
blocked with 5 % nonfat milk for 2 h at room temperature.
The following antibodies were used as primary antibodies:
rabbit anti-Fas antibody (ab82419, Abcam Ltd, HongKong,
1:200 dilution), rabbit anti-FasL antibody (sc-834, Santa
Cruz Biotechnology, USA, 1:200 dilution), and mouse an-
ti-beta actin monoclonal antibody (AA128, Beyotime Insti-
tute of Biotechnology, China, 1:1,000 dilution), followed by
the goat polyclonal secondary antibody to rabbit IgG-H&L-
HRP (ab6721, Abcam Ltd, Hong Kong, 1:1,000 dilution) or
to mouse IgG-H + L-HRP (A0216, Beyotime Institute of
Biotechnology, China, 1:1,000 dilution). Blots were ex-
posed for 60 s to BeyoECL Plus (P0018, Beyotime Institute
of Biotechnology, China). The images ofWestern blots were
scanned by ChemiDocTM XRS (Bio-Rad, USA), acquired,
and analyzed by using Quantity One software (Bio-Rad,
USA). Protein levels were expressed as density and were
normalized to beta-actin for statistical comparisons [33].
Immunohistochemistry. The spleen was fixed in 10 %
neutral formaldehyde and embedded in paraffin wax. The 4-
μm-thick sections were dewaxed in xylene and rehydrated
by taking through a graded series of ethanol. The endoge-
nous peroxidase activity was blocked with 3 % hydrogen
peroxide for 15 min. Sections were incubated with rabbit
anti-Fas antibody (ab82419, Abcam Ltd, Hong Kong, 1:100
dilution) or rabbit anti-FasL antibody (sc-834, Santa Cruz
Biotechnology, USA, 1:200 dilution) overnight at 4°C and
then incubated with goat polyclonal secondary antibody to
rabbit IgG-H&L-HRP (ab6721, Abcam Ltd, Hong Kong,
Table 1. Measurements of Serum of Lipase and Amylase Activities
Control Cn (MAP group) Cn + LPS (SAP group)
Amylase (U/L) 242.90±15.54 2,638.90±166.84a 6,743.95±283.67ab
Lipase (U/L) 61.20±3.38 385.30±23.960a 1,360.80±57.14ab
n=10 in control and Cn groups; n=20 in Cn + LPS group
Cn caerulein (6×5 μg/kg); Cn + LPS caerulein (6×50 μg/kg) + lipopolysaccharide (1×10 mg/kg)
a p<0.01 vs. control group
b p<0.01 vs. Cn group
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1:500 dilution) for 30 min at 37 °C. Negative controls were
incubated with normal rabbit serum instead of the first anti-
body. Finally, sections were stained by using a 3,3'-diamino-
benzidine (DAB) kit (Maixin Biotechnology Company, Chi-
na) and counterstained with hematoxylin, dehydrated
through a graded series of ethanol solutions, cleared with
xylene, and mounted with coverslips. The analysis was
performed using a scoring system as described previously
[35]. All the slides were scored by two pathologists who
were blinded to the pathology and experimental protocol.
Apoptosis TUNEL Assay. The TUNEL assay was per-
formed using an in situ cell death detection kit, peroxidase-
based secondary detection systems (POD) (11684817910,
Roche Applied Science, Germany), according to the man-
ufacturer’s instructions. After incubation with the TUNEL
reactionmixture containing TdTand fluorescein-dUTP, the
sections of the spleen were analyzed under a fluorescence
microscope (Olympus, Japan, excitation wavelength in the
range of 450–500 nm and detection in the range of 515–
565 nm). The cells were finally incubated with converter-
POD, stained by using a DAB kit (Maixin Biotechnology
Company, China), and counterstained with hematoxylin. A
light microscope was used to count cells in ten randomly
selected high-power field areas (×400) without necrosis per
slide. The apoptosis index (AI) was defined as the percentage
of TUNEL-positive cells to all counted cells.
Table 2. Histological Scoring of Pancreatic Injury
Edema Acinar necrosis Inflammation Hemorrhage
Control 0.0 0.0 0.0 0.0
Cn (MAP group) 1.50±0.13 0.10±0.07 1.05±0.12 0.0
Cn + LPS (SAP group) 3.05±0.11a 2.68±0.13a 2.83±0.13a 1.28±0.14a
n=10 in control and Cn groups; n=20 in Cn + LPS group
Cn caerulein (6×5 μg/kg); Cn + LPS caerulein (6×50 μg/kg) and lipopolysaccharide (1×10 mg/kg)
a p<0.01 vs. Cn group
Fig. 1. Hematoxylin and eosin staining of pancreas tissue sections. a Animals of the control group displayed normal pancreatic histology. b Animals of the
caerulein (Cn) group (MAP group) treated with caerulein (6×5 μg/kg) showed mild edematous pancreatitis characterized by interstitial edema and slight
infiltration of inflammatory cells but without obvious acinar necrosis and parenchymal hemorrhage. c, dAnimals of the Cn + LPS group (SAP group) treated
with caerulein (6×50 μg/kg) and lipopolysaccharide (1×10mg/kg) showed the features of severe acute pancreatitis characterized by severe interstitial edema
of interlobular and intralobular spaces, extensive infiltration with inflammatory cells, obvious acinar necrosis, and parenchyma hemorrhage
(original magnification ×400).
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Flow Cytometry Analysis. Blood samples were collected
into sterile tubes containing EDTA anticoagulant. Fifty mi-
croliters of blood was incubated (in the absence of light) in
TruCountTM tubes with lymphocyte subset antibodies (anti-
mouse CD3 APC-eFluor 780 17A2, anti-mouse CD4 APC
GK1.5, anti-mouse CD8a PE 53-6.7, and anti-mouse CD19
PE-Cy7 eBio1D3 (1D3) were from eBioscience, USA ) at
25 °C for 15 min. Matched labeled isotype antibodies were
used as negative controls (rat IgG2b K Isotype control APC-
eFluor 780, rat IgG2b K Isotype control APC, rat IgG2a K
Fig. 2. The semiquantitative analysis of a Fas mRNA and b FasL mRNA in splenic lymphocytes by real-time PCR. The relative gene expression was
calculated by 2−ΔΔCt method. *p<0.01 vs. control group andMAP group; △p<0.01 vs. SAP group without infectious complications (A control group; BMAP
group; C SAP group without infectious complications; D SAP group with infectious complications).
Fig. 3. Immunohistochemistry of Fas and FasL protein of spleen tissue sections. Immunohistochemical analysis shows that Fas protein (a–d) and FasL
protein (e–h) accumulate in the cell membrane and cytoplasm of splenic lymphocytes. Compared with the control (a, e) and MAP groups (b, f), the staining
intensity and number of cells expressing Fas and FasL increased markedly in the SAP group (c, d, g, h), especially in those animals with infectious com-
plications (d, h; original magnification ×400).
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Isotype control PE, and rat IgG2a K Isotype control PE-Cy7
were from eBioscience, USA). Then, the samples were
treated with 450 μL 1× BD FACS lysing solution
(BD Company, USA). After the erythrocytes were
lysed, 10,000 cells along with beads were acquired
on a FACSCanto™ II flow cytometer (BD Company,
USA). The results were analyzed using FACSDiva
software (BD Company, USA).
Statistical Analysis. Results are expressed as mean±
SEM. After the homogeneity test of variance (Levene’s
test), the results were analyzed by one-way ANOVA
fol lowed by pos t hoc mult ip le compar i sons
(Bonferroni test); p<0.05 was accepted as statistically
significant. Correlation between the expression levels
of Fas and FasL protein and lymphocyte apoptosis and
CD4+ and CD19+ lymphocytes and CD4+/CD8+ ratio
was evaluated by Pearson’s correlation coefficient. P<0.05
was considered statistically significant.
RESULTS
Biochemical and Histological Findings
Intraperitoneal injection of caerulein and LPS was
associated with significant increases in the serum levels
of lipase and amylase (Table 1) and resulted in SAP.
Histological examination of pancreas at 12 h after caerulein
and LPS administration revealed tissue damage char-
acterized by edema, acinar necrosis, inflammation, and
hemorrhage (Table 2 and Fig. 1).
Infectious Complications in SAP
Bacterial cultures showed that no bacterium was
observed from the MLN complex or the pancreas in
both the control and MAP groups. In the SAP group,
positive rates of bacterial culture from the MLN com-
plex and pancreas were 45 % (9/20) and 60 % (12/20),
respectively, at 12 h after caerulein and LPS adminis-
tration. E. coli was cultured most frequently from the
MLN (77 %, 7/9) and pancreas (83 %, 10/12), follow-
ed by Proteus characterized at 33 % (3/9) from MLN
and 42 % (5/12) from pancreas. Positive rates of En-
terococcus from MLN and pancreas were 45 % (4/9)
and 33 % (4/12), respectively. Pancreatic infection was
regarded as a sign of infectious complications in this
study.
Expression of Fas and FasL mRNA in Lymphocytes
from the Spleen
Analysis by real-time PCR indicated that the expres-
sion levels of Fas and FasL messenger ribonucleic acid
(mRNA) were increased significantly in the SAP group
compared with the MAP and control groups (p<0.01 in all
cases). There was a further increase in the SAP group with
infectious complications compared to those without
(p<0.01 in all cases). The expression of Fas and
FasL mRNA also increased in the MAP group, but
there was no significant difference compared with the
control group (Fig. 2a, b).
Localization and Expression Level of Fas and FasL
Protein in Lymphocytes from the Spleen
Immunohistochemistry analysis revealed that Fas and
FasL proteins were expressed in the cell membrane
and cytoplasm of splenic lymphocytes. The staining
intensity and number of cells expressing Fas and FasL
increased markedly in the SAP group, especially in
those mice with infectious complications, when com-
pared to the control group (Fig. 3). The expression
levels of Fas and FasL protein in splenic lymphocytes
were significantly increased in the SAP group as
detected by Western blotting, and these changes were
Fig. 4. Western blot analysis of Fas and FasL protein in splenic lympho-
cytes. Protein levels were expressed as density and were normalized to
beta-actin. *p<0.01 vs. control and MAP groups; △p<0.01 vs. SAP group
without infectious complications; #p<0.01 vs. control group (1 control
group; 2 MAP group; 3 SAP group without infectious complications; 4
SAP group with infectious complications).
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more significant in those mice with infectious complications
(p<0.01 in all cases; Fig. 4).
Apoptosis in Lymphocytes from the Spleen
TUNEL-positive splenic lymphocytes displayed bril-
liant green fluorescence under the fluorescence microscope
(Fig. 5a–d). After incubation with the converter-POD and
counterstained with hematoxylin, apoptotic nuclei were
stained brown when observed under a light microscope
(Fig. 5e–h). The number of positive cells increased mark-
edly in the SAP group, especially in those mice with
infectious complications, when compared to the control
group. The AIs of the SAP group were significantly greater
than those of the control and MAP groups (p<0.01). There
Fig. 5. TUNEL staining of splenic lymphocytes of spleen tissue sections. a–d TUNEL-positive splenic lymphocytes displayed brilliant green fluorescence
under a fluorescence microscope. e–h After sections were incubated with the converter-POD and counterstained with hematoxylin, apoptotic nuclei were
stained brown when observed under a light microscope. Only a few apoptotic cells were visible in the control (a, e) and MAP groups (b, f). The number of
apoptotic cells increased markedly in the SAP group (c, d, g, h), especially in those animals with infectious complications (d, h; original magnification ×400).
Fig. 6. The apoptosis index (AI) of splenic lymphocytes. Apoptosis was
assessed by TUNEL. *p<0.01 vs. control and MAP groups; △p<0.01 vs.
SAP group without infectious complications (A control group; B MAP
group; C SAP group without infectious complications; D SAP group with
infectious complications).
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was a further increase in AI in the SAP group with
infectious complications when compared to those without
(p<0.01; Fig. 6).
Changes in Circulating Lymphocyte Subsets
The percentage of lymphocyte subsets (CD3+,
CD4+, and CD19+) and the CD4+/CD8+ ratio were
decreased significantly in the SAP group compared
with the MAP and control groups (p<0.01 or p<
0.05), and there was a further decrease in the SAP
group with infectious complications when compared
to those without (p<0.01 or p<0.05). No significant
changes of lymphocyte subsets were found between
the MAP and control groups, and there was no
significant change in the percentage of CD8+ T-cell
ratio between each group (Fig. 7a, b).
Correlation Between the Expression of Fas and FasL
Protein and Apoptosis of Lymphocytes and
Lymphocyte Subsets
There was a significant positive relationship between
Fas/FasL protein expression and AI (Fig. 8a, b), and there
was a significant negative relationship between Fas/FasL
protein expression and CD4+ (Fig. 8c, d) and CD19+
(Fig. 8g, h) lymphocyte subsets as well as the CD4+/
CD8+ ratio (Fig. 8e, f) in SAP group (p<0.05 in all cases).
DISCUSSION
The histological changes including edema, acinar ne-
crosis, inflammation, and hemorrhage after the administra-
tion of caerulein and LPS in the SAP group in this study
indicate the successful replication of the mouse model
described in previous studies [27–30]. LPS clearly dam-
ages the functional intestinal barrier, which results in an
increase of mucosal permeability, and this is considered to
be a major promoter of bacterial translocation (BT) [36].
Intraperitoneal injection of LPS could mimic infection by
increasing gut paracellular permeability and inducing BT
[37–39]. Gut paracellular permeability was significantly
higher at 6 h after LPS injection [39].
Lymphocytes play an important immunological role
in acute pancreatitis. Significant reduction of lymphocytes
may lead to immunological impairment. Several studies
have reported depletion of circulating lymphocytes in acute
pancreatitis [40–42], especially CD4-positive lymphocytes
[43]. Significant decreases in CD4- and CD8-positive pe-
ripheral lymphocytes may cause immune suppression in
the early phase of SAP and could be closely related to
infectious complications [5]. In this study, ratios of circu-
lating lymphocyte subsets were decreased significantly in
the SAP group, including CD3+ cells, CD4+ T-cells, CD4+/
CD8+ ratio, and CD19+ cells. There was a further decrease
in the SAP group with infectious complications when
compared to mice without infectious complication. While
there was no significant change of lymphocyte subsets
between the MAP and control groups and there was a
small change in the CD8+ T-cells between each group,
this result was consistent with an immunological
impairment in the SAP group, especially in those with
infectious complications.
Experiments have shown that the reduction of periph-
eral lymphocytes was primarily due to lymphocyte apo-
ptosis [44]. Extensive apoptosis of lymphocytes, including
B and T lymphocytes in peripheral blood and lymphocytes
Fig. 7. Changes of circulating a lymphocyte subsets and b CD4+/CD8+
ratio. *p<0.01 vs. SAP group with or without infectious complications and
SAP group with infectious complications; △p<0.05 vs. SAP group without
infectious complications; △p<0.01 vs. SAP group with infectious
complications; #p<0.01 vs. SAP group with infectious complications;
p▲<0.05 vs. SAP group with infectious complications (A control group;
B MAP group; C SAP group without infectious complications; D SAP
group with infectious complications).
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from the spleen and thymus, was observed during sepsis
and SAP [12, 45, 46]. Prevention of lymphocyte apoptosis
improves immunological impairment and survival in sepsis
[12, 13]. Our study also found a significantly increased
number of apoptotic lymphocytes and a high AI in the
spleen of the SAP group, especially in those mice with
infectious complications. Extensive apoptosis of lympho-
cytes may be the main mechanism for the reduction of
lymphocyte subsets in SAP.
Apoptosis is important to maintain adequate lympho-
cyte development and homeostasis. It is well-known that
differentiation, maturation, activation, and deletion of T
and B cells in the peripheral immune system are regulated
mainly by Fas/FasL signaling [47, 48]. Activation-induced
cell death (AICD) is involved in the elimination of
activated T cells and is mainly mediated by Fas–FasL
interactions [49, 50]. The results of this study show that
there is overexpression of Fas and FasLmRNA and protein
in the SAP group, especially in those mice with infectious
complications. These results indicate that abnormal expres-
sion of Fas and FasL may be major factors involved in the
dysregulation of functional lymphocytes.
A significant positive relationship between Fas and
FasL protein expression and AI and significant negative
relationships between Fas and FasL protein expression and
CD4+ and CD19+ lymphocyte subsets as well as CD4+/
CD8+ ratio were found in the SAP group. Exaggerated
inflammatory responses leading to massive release of
various cytokines following an excessive activation of
lymphocytes and excessive immune response can result
Fig. 8. Correlations between the expression of Fas and FasL protein and apoptosis index (AI) and CD4+ and CD19+ lymphocytes and CD4+/CD8+ ratio. The
data show a significant positive relationship between Fas and FasL protein expression and AI (a, b) and significant negative relationships between Fas and
FasL protein expression and CD4+ T cell (c, d), CD4+/CD8+ ratio (e, f), and CD19+ B cell (g, h) in the SAP group (p<0.05 in all cases).
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in a negative regulation via overexpression of Fas and
FasL. Subsequent excessive apoptosis of lymphocytes
and reduction of lymphocyte subsets can render the host
to suffer from the suppression of cellular and humoral
immune responses [51, 52]. Our previous study also
confirmed that the overexpression of Fas is associated
with immunosuppression and sepsis complications in
patients with SAP [53].
In conclusion, our study demonstrates that there is an
overexpression of Fas and FasL mRNA and protein, ex-
cessive apoptosis of lymphocytes, and a marked reduction
of circulating lymphocyte subsets in experimental SAP in
mice. The results indicate that the overexpression of Fas
and FasL is associated with infectious complications and
severity of experimental SAP by promoting apoptosis of
lymphocytes.
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